CLDN18 and gastric cancer: Therefore, for more precise stratification of claudin 18.2-overexpressing gastric cancer, efforts should be made to delineate additional (genetic) biomarkers such as CLDN18-ARHGAP26/6 fusions, which are reportedly more prevalent in diffuse-type gastric cancers that involve lymphatic and distant metastases18.